Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   

CHEBI ONTOLOGY - ANNOTATIONS

The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.

Term:19-hydroxy steroid
go back to main search page
Accession:CHEBI:36842 term browser browse the term
Synonyms:related_synonym: 19-hydroxy steroids


show annotations for term's descendants           Sort by:
 
andrastin A term browser
Symbol Object Name Qualifiers Evidence Notes Source PubMed Reference(s) RGD Reference(s) Position
G Csf2 colony stimulating factor 2 multiple interactions ISO andrastin A results in increased expression of and results in increased secretion of CSF2 protein CTD PMID:28535995 NCBI chr10:39,602,089...39,604,070
Ensembl chr10:39,602,089...39,604,070
JBrowse link
G Tgfb1 transforming growth factor, beta 1 multiple interactions ISO andrastin A results in increased expression of and results in increased secretion of TGFB1 protein CTD PMID:28535995 NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
JBrowse link
G Tnf tumor necrosis factor multiple interactions ISO andrastin A results in increased expression of and results in increased secretion of TNF protein CTD PMID:28535995 NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
JBrowse link

Term paths to the root
Path 1
Term Annotations click to browse term
  CHEBI ontology 19816
    chemical entity 19816
      molecular entity 19814
        polyatomic entity 19727
          heteroatomic molecular entity 19653
            hydroxides 19107
              organic hydroxy compound 18661
                hydroxy steroid 12380
                  19-hydroxy steroid 3
                    19-hydroxy-5alpha-dihydrotestosterone 0
                    19-hydroxyandrost-4-ene-3,17-dione 0
                    19-hydroxytestosterone 0
                    andrastin B + 3
                    dihydroouabagenin 0
                    ouabagenin + 0
                    withalongolide A 0
                    withalongolide D 0
                    withalongolide G 0
                    withalongolide I 0
                    withalongolide J 0
Path 2
Term Annotations click to browse term
  CHEBI ontology 19816
    subatomic particle 19814
      composite particle 19814
        hadron 19814
          baryon 19814
            nucleon 19814
              atomic nucleus 19814
                atom 19814
                  main group element atom 19702
                    p-block element atom 19702
                      carbon group element atom 19608
                        carbon atom 19597
                          organic molecular entity 19597
                            organic molecule 19522
                              organic cyclic compound 19320
                                organic polycyclic compound 16395
                                  steroid 12800
                                    hydroxy steroid 12380
                                      19-hydroxy steroid 3
                                        19-hydroxy-5alpha-dihydrotestosterone 0
                                        19-hydroxyandrost-4-ene-3,17-dione 0
                                        19-hydroxytestosterone 0
                                        andrastin B + 3
                                        dihydroouabagenin 0
                                        ouabagenin + 0
                                        withalongolide A 0
                                        withalongolide D 0
                                        withalongolide G 0
                                        withalongolide I 0
                                        withalongolide J 0
paths to the root

NHLBI Logo

RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.